Effect of capsaicin inhalation on methacholine responsiveness in normal subjects
- PMID: 8924757
- DOI: 10.1007/BF02291406
Effect of capsaicin inhalation on methacholine responsiveness in normal subjects
Abstract
It has been reported that capsaicin stimulates bronchial C-fibers to release neuropeptides and enhances bronchial responsiveness in animal studies. This study was conducted to examine the effect of inhaled capsaicin on bronchial responsiveness in humans. A provocative concentration of methacholine producing a 20% fall in forced expiratory volume in one second (PC20-FEV1) was measured before and one hour after, one minute inhalation of 15.6 microM capsaicin solution (capsaicin day) or saline (saline day) in seven normal subjects whose PC20-FEV1 values were 40 mg/ml or less. Geometric mean value of PC20-FEV1 measured one hour after saline inhalation following pretreatment methacholine challenge was 89.3 (GSEM, 1.69) mg/ml which was significantly (p = 0.018) greater than that of the pre-treatment methacholine challenge [19.1 (GSEM, 1.37) mg/ml] on a saline day. However, PC20-FEV1 was not different before and one hour after inhalation of capsaicin [18.1 (GSEM, 1.40) and 23.1 (GSEM, 1.80) mg/ml] on a capsaicin day. The PC20-FEV1 value of the post-treatment methacholine test was significantly (p = 0.0277) lower after capsaicin inhalation than after saline inhalation while the value of pre-treatment methacholine provocation was not different between capsaicin and saline days. Change of the post-treatment PC20-FEV1 from the pre-treatment value shown as doubling concentrations was 0.35 +/- 0.60 on a capsaicin day which was significantly lower than that (2.23 +/- 0.47) on a saline day. These results confirm the decreased responses to repeated inhalation of methacholine (methacholine tachyphylaxis) in normal subjects and indicate that capsaicin inhalation reduces the methacholine tachyphylaxis.
Similar articles
-
Airway cough sensitivity to inhaled capsaicin and bronchial responsiveness to methacholine in asthmatic and bronchitic subjects.Respirology. 1998 Dec;3(4):267-72. doi: 10.1111/j.1440-1843.1998.tb00133.x. Respirology. 1998. PMID: 10201054
-
Duration of tachyphylaxis in response to methacholine in healthy non-asthmatic subjects.Respirology. 1999 Mar;4(1):47-51. doi: 10.1046/j.1440-1843.1999.00151.x. Respirology. 1999. PMID: 10339730 Clinical Trial.
-
Comparison of two standardized methods of methacholine inhalation challenge in young adults.Eur Respir J. 2000 Jan;15(1):181-4. doi: 10.1183/09031936.00.15118100. Eur Respir J. 2000. PMID: 10678643 Clinical Trial.
-
Provocative dose of methacholine causing a 20% drop in FEV1 should be used to interpret methacholine challenge tests with modern nebulizers.Ann Am Thorac Soc. 2015 Mar;12(3):357-63. doi: 10.1513/AnnalsATS.201409-433OC. Ann Am Thorac Soc. 2015. PMID: 25575246 Clinical Trial.
-
Comparative bronchial responses to hyperosmolar saline and methacholine in asthma.Thorax. 1987 Dec;42(12):953-8. doi: 10.1136/thx.42.12.953. Thorax. 1987. PMID: 3438883 Free PMC article. Clinical Trial.
Cited by
-
Peripheral mechanisms II: the pharmacology of peripherally active antitussive drugs.Handb Exp Pharmacol. 2009;187(187):155-86. doi: 10.1007/978-3-540-79842-2_8. Handb Exp Pharmacol. 2009. PMID: 18825340 Free PMC article. Review.